Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLoose, watery stools are one of the more disruptive side effects some people experience on Mounjaro (tirzepatide). They tend to arrive early in treatment, often in the first few weeks or after a dose increase, and for most people settle down as the body adjusts. That said, the decision you're actually facing isn't whether to worry — it's whether what you're experiencing is the expected kind, or a signal that needs prompt attention. Mounjaro is a prescription-only medicine reviewed by a qualified prescriber before and during treatment, so you're not navigating this alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro activates two gut-hormone receptors, GIP and GLP-1, that are involved in appetite regulation and blood-sugar control. One of the knock-on effects is that it slows how quickly food moves through the stomach. That change in gastric transit alters the environment further along the digestive tract, and for a significant number of people, the result is loose or watery stools, particularly in the early weeks of treatment.
The NHS medicines page for tirzepatide lists diarrhoea among the common side effects, meaning it affects roughly one in ten or more people who take the medicine. The watery quality, rather than just looseness, reflects how quickly the gut is moving fluid that would normally be reabsorbed. It is unpleasant, but it is mechanistically predictable.
Episodes most often peak in the days following a new pen or after moving up a dose. If you started 5 mg last Tuesday, watery stools mid-week are more likely tied to the adjustment than to anything else. Most people find the pattern settles within one to three weeks as the gut recalibrates, though this varies by individual, and some people experience diarrhoea throughout treatment at a lower level.
The key question is whether your symptoms fit the expected pattern or have drifted outside it. Features that generally sit in the manageable category: onset within the first couple of weeks of a new dose, loose or watery consistency without visible blood, passing in under a week, and an ability to keep fluids down. The full side-effect picture for Mounjaro covers how nausea, constipation and gut discomfort interact with diarrhoea episodes, which can help you recognise where yours sits.
At home, the practical priorities are hydration and salt balance. Water alone is less effective than water alongside foods or drinks containing some electrolytes, plain rice, toast, or diluted fruit juice alongside plain water all help. Avoid high-fat foods while symptoms are active, since fat intake can aggravate GI symptoms on a GLP-1 or dual agonist medicine. Some people find smaller, more frequent meals easier to manage than three full ones.
Timing matters more than people expect. If your dose lands on a Friday and symptoms peak over the weekend, replacing fluids can be harder than midweek, something worth factoring in if you have flexibility over when you administer your weekly injection. That said, consistency of day matters too, so discuss any change with your prescriber rather than shifting it unilaterally.
Some features should prompt you to contact a GP or call 111 rather than waiting for things to improve. Diarrhoea that has lasted more than a week without any sign of settling, or that is so frequent you cannot maintain adequate hydration, is outside the expected adjustment window. Signs of dehydration (feeling dizzy when you stand up, very dark urine, a dry mouth, or passing very little urine) mean you need to act that day, not the next morning.
Severe abdominal pain is the more urgent signal. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines, specifically highlighting acute pancreatitis as a serious but infrequent risk: the key symptom pattern is intense, persistent stomach pain that radiates toward the back, which may or may not come with vomiting. That is not a wait-and-see symptom. Seek emergency care. You can read more about what the clinical picture looks like when diarrhoea after Mounjaro crosses into a concern, including the distinction between gastric adjustment and something more acute.
If you notice blood in your stools at any point, or a fever alongside gut symptoms, contact your GP. And if something simply feels wrong in a way that goes beyond the expected early-adjustment experience, that instinct is worth following up on. Our prescribers are reachable through our aftercare team, seven days a week, for exactly these questions.
If you experience watery diarrhoea that you feel was significant (whether or not it needed medical attention) reporting it via the MHRA Yellow Card scheme helps build the safety picture for this medicine. Mounjaro carries a Black Triangle (▼) status, meaning the MHRA actively requests reports from patients and healthcare professionals as part of ongoing monitoring. You don't need to be certain that Mounjaro caused the symptom to report it; suspicion is enough.
Within your own treatment, persistent or severe GI side effects are sometimes a signal that the current dose is moving up faster than your body is comfortable with. A prescriber can discuss whether the titration pace is right for you, or whether supportive measures might help. That conversation is part of the clinical review that comes with every prescription at nume, it's not just a formality. If you'd like to understand what else falls within the broader category, the overview of Mounjaro and diarrhoea covers the full range of presentations people report.
For those still weighing whether Mounjaro is suitable for them, our prescribers discuss suitability and side effects openly as part of the consultation. Check your eligibility and start a free consultation to see whether treatment is clinically appropriate for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.